JENNIFER BERKOWITZ: Open Payments
NPI 1528454568 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 32 payments from 13 companies in 2025. Trend: 2023 $440 · 2024 $564 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 5 | $106 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| Exeltis, USA Inc. | 4 | $67 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $64 |
| SHIELD THERAPEUTICS INC | 2 | $62 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| MILLICENT US INC | 2 | $30 |
| Smith+Nephew, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $18 |
Products named: ZURZUVAE, MYFEMBREE, SLYND, ACCRUFER, Qelbree, INTRAROSA, STRAVIX PL, Veozah.
Industry payments across PA — which companies pay providers there.
